Article info
PDFClinical ethics
Paper
Understanding preferences for disclosure of individual biomarker results among participants in a longitudinal birth cohort
- Correspondence to Dr Stephen E Wilson, 231 Albert Sabin Way, Room 6601, Cincinnati, OH 45267-0535, USA; stephen.wilson{at}uc.edu
Citation
Understanding preferences for disclosure of individual biomarker results among participants in a longitudinal birth cohort
Publication history
- Received March 5, 2010
- Revised July 28, 2010
- Accepted August 13, 2010
- First published October 8, 2010.
Online issue publication
April 27, 2016
Article Versions
- Previous version (27 April 2016).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© 2010, Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions.
Other content recommended for you
- Disclosure of individual research results in clinico-genomic trials: challenges, classification and criteria for decision-making
- Acknowledging awareness: informing families of individual research results for patients in the vegetative state
- Awareness, experiences and perceptions regarding genetic testing and the return of genetic and genomics results in a hypothetical research context among patients in Uganda: a qualitative study
- Faecal biomarker patterns in patients with symptoms of irritable bowel syndrome
- Informing research participants of research results: analysis of Canadian university based research ethics board policies
- Anticipated health behaviour changes and perceived control in response to disclosure of genetic risk of breast and ovarian cancer: a quantitative survey study among women in the UK
- Remote data collection speech analysis and prediction of the identification of Alzheimer’s disease biomarkers in people at risk for Alzheimer’s disease dementia: the Speech on the Phone Assessment (SPeAk) prospective observational study protocol
- Oncologist-led BRCA counselling improves access to cancer genetic testing in middle-income Asian country, with no significant impact on psychosocial outcomes
- Synovial tissue and serum biomarkers of disease activity, therapeutic response and radiographic progression: analysis of a proof-of-concept randomised clinical trial of cytokine blockade
- Clinical utility of cerebrospinal fluid biomarkers in the evaluation of cognitive impairment: a systematic review and meta-analysis